Tumor-infiltrating dendritic cells exhibit defective cross-presentation of tumor antigens, but is reversed by chemotherapy

CD8+ Tumor-Infiltrating T Cells Are Trapped in the Tumor-Dendritic Cell Network

(2015) Alexandre Boissonnas et al.   NEOPLASIA

Defective MHC Class II Presentation by Dendritic Cells Limits CD4 T Cell Help for Antitumor CD8 T Cell Responses

(2014) M. Y. Gerner et al.   JOURNAL OF IMMUNOLOGY

Anticancer Chemotherapy-Induced Intratumoral Recruitment and Differentiation of Antigen-Presenting Cells

(2013) Yuting Ma et al.   IMMUNITY

Increased Numbers of Monocyte-Derived Dendritic Cells during Successful Tumor Immunotherapy with Immune-Activating Agents

(2013) S. Kuhn et al.   JOURNAL OF IMMUNOLOGY

Agonistic Anti-CD40 Antibody Therapy is Effective Against Postoperative Cancer Recurrence and Metastasis in a Murine Tumor Model

(2013) Andrea Khong et al.   JOURNAL OF IMMUNOTHERAPY

Synergistic Effect of CTLA-4 Blockade and Cancer Chemotherapy in the Induction of Anti-Tumor Immunity

(2013) W. Joost Lesterhuis et al.   PLoS One

Programmed Death Ligand 2 in Cancer-Induced Immune Suppression

(2012) Esdy N. Rozali et al.   Clinical & Developmental Immunology

The specialized roles of immature and mature dendritic cells in antigen cross-presentation

(2012) Richard A. Hopkins et al.   IMMUNOLOGIC RESEARCH

Stromal Interferon-γ Signaling and Cross-Presentation Are Required to Eliminate Antigen-Loss Variants of B Cell Lymphomas in Mice

(2012) Armin Gerbitz et al.   PLoS One

Tumor cells, rather than dendritic cells, deliver antigen to the lymph node for cross-presentation

(2012) Alison M. McDonnell et al.   OncoImmunology

Platinum-based drugs disrupt STAT6-mediated suppression of immune responses against cancer in humans and mice

(2011) W. Joost Lesterhuis et al.   JOURNAL OF CLINICAL INVESTIGATION

Murine Melanoma-Infiltrating Dendritic Cells Are Defective in Antigen Presenting Function Regardless of the Presence of CD4+CD25+ Regulatory T Cells

(2011) Haley Ataera et al.   PLoS One

Tumor Antigen Cross-Presentation and the Dendritic Cell: Where it All Begins?

(2010) Alison M. McDonnell et al.   Clinical & Developmental Immunology

CD8α+ DC are not the sole subset cross-presenting cell-associated tumor antigens from a solid tumor

(2010) Alison M. McDonnell et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Tumor masses support naive T cell infiltration, activation, and differentiation into effectors

(2010) Elizabeth D. Thompson et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Antigen Processing and MHC-II Presentation by Dermal and Tumor-Infiltrating Dendritic Cells

(2009) M. Y. Gerner et al.   JOURNAL OF IMMUNOLOGY

Dendritic cell subsets in primary and secondary T cell responses at body surfaces

(2009) William R Heath et al.   NATURE IMMUNOLOGY

Inefficient presentation of tumor-derived antigen by tumor-infiltrating dendritic cells

(2008) Patrizia Stoitzner et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Prevention of Both Direct and Cross-Priming of Antitumor CD8+ T-Cell Responses following Overproduction of Prostaglandin E2 by Tumor Cells In vivo

(2008) M. Ahmadi et al.   CANCER RESEARCH

Cancer Immunotherapy by Dendritic Cells

(2008) Cornelis J.M. Melief   IMMUNITY

Protective influenza-specific CD8 T cell responses require interactions with dendritic cells in the lungs

(2008) Jodi McGill et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Dendritic Cell-Induced Memory T Cell Activation in Nonlymphoid Tissues

(2008) L. M. Wakim et al.   SCIENCE